rs7180446

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152594.3(SPRED1):​c.424-8C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.882 in 1,612,586 control chromosomes in the GnomAD database, including 629,837 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 52403 hom., cov: 30)
Exomes 𝑓: 0.89 ( 577434 hom. )

Consequence

SPRED1
NM_152594.3 splice_region, intron

Scores

2
Splicing: ADA: 0.005107
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.863

Publications

16 publications found
Variant links:
Genes affected
SPRED1 (HGNC:20249): (sprouty related EVH1 domain containing 1) The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). [provided by RefSeq, Jul 2008]
SPRED1 Gene-Disease associations (from GenCC):
  • Legius syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, ClinGen, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 15-38339729-C-A is Benign according to our data. Variant chr15-38339729-C-A is described in ClinVar as Benign. ClinVar VariationId is 41453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPRED1NM_152594.3 linkc.424-8C>A splice_region_variant, intron_variant Intron 4 of 6 ENST00000299084.9 NP_689807.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPRED1ENST00000299084.9 linkc.424-8C>A splice_region_variant, intron_variant Intron 4 of 6 1 NM_152594.3 ENSP00000299084.4
SPRED1ENST00000561317.1 linkc.361-8C>A splice_region_variant, intron_variant Intron 5 of 5 4 ENSP00000453680.1

Frequencies

GnomAD3 genomes
AF:
0.824
AC:
125209
AN:
151918
Hom.:
52390
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.663
Gnomad AMI
AF:
0.748
Gnomad AMR
AF:
0.841
Gnomad ASJ
AF:
0.902
Gnomad EAS
AF:
0.792
Gnomad SAS
AF:
0.879
Gnomad FIN
AF:
0.934
Gnomad MID
AF:
0.832
Gnomad NFE
AF:
0.897
Gnomad OTH
AF:
0.829
GnomAD2 exomes
AF:
0.865
AC:
217263
AN:
251082
AF XY:
0.873
show subpopulations
Gnomad AFR exome
AF:
0.653
Gnomad AMR exome
AF:
0.826
Gnomad ASJ exome
AF:
0.909
Gnomad EAS exome
AF:
0.789
Gnomad FIN exome
AF:
0.934
Gnomad NFE exome
AF:
0.896
Gnomad OTH exome
AF:
0.871
GnomAD4 exome
AF:
0.888
AC:
1296882
AN:
1460550
Hom.:
577434
Cov.:
42
AF XY:
0.889
AC XY:
645933
AN XY:
726618
show subpopulations
African (AFR)
AF:
0.646
AC:
21576
AN:
33398
American (AMR)
AF:
0.832
AC:
37194
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.907
AC:
23677
AN:
26110
East Asian (EAS)
AF:
0.784
AC:
31063
AN:
39638
South Asian (SAS)
AF:
0.892
AC:
76930
AN:
86226
European-Finnish (FIN)
AF:
0.933
AC:
49763
AN:
53348
Middle Eastern (MID)
AF:
0.840
AC:
4838
AN:
5758
European-Non Finnish (NFE)
AF:
0.899
AC:
999047
AN:
1111028
Other (OTH)
AF:
0.875
AC:
52794
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
7321
14641
21962
29282
36603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21386
42772
64158
85544
106930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.824
AC:
125273
AN:
152036
Hom.:
52403
Cov.:
30
AF XY:
0.826
AC XY:
61370
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.663
AC:
27488
AN:
41444
American (AMR)
AF:
0.842
AC:
12845
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.902
AC:
3129
AN:
3470
East Asian (EAS)
AF:
0.792
AC:
4090
AN:
5164
South Asian (SAS)
AF:
0.879
AC:
4229
AN:
4812
European-Finnish (FIN)
AF:
0.934
AC:
9888
AN:
10588
Middle Eastern (MID)
AF:
0.830
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
0.897
AC:
60940
AN:
67974
Other (OTH)
AF:
0.822
AC:
1738
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1041
2081
3122
4162
5203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.872
Hom.:
114544
Bravo
AF:
0.805
Asia WGS
AF:
0.794
AC:
2764
AN:
3478
EpiCase
AF:
0.889
EpiControl
AF:
0.886

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Mar 14, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

424-8C>A in intron 4 of SPRED1: This variant is not expected to have clinical si gnificance because it has been identified in 90% (6302/7020) of European America n chromosomes and 69% (2574/3738) of African American chromosomes from a broad p opulation by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EV S/; dbSNP rs7180446). -

Jul 14, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Legius syndrome Benign:6
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Apr 17, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The SPRED1 c.424-8C>A variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant. 4/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 104727/121254 control chromosomes (45629 homozygotes) from ExAC at a frequency of 0.8636993 at a frequency of 0.8636993, which is approximately 345479 times the estimated maximal expected allele frequency of a pathogenic SPRED1 variant (0.0000025), therefore this variant is a benign common polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
3.9
DANN
Benign
0.67
PhyloP100
-0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0051
dbscSNV1_RF
Benign
0.082
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7180446; hg19: chr15-38631930; COSMIC: COSV54434951; API